Clinical Trials Directory

Trials / Completed

CompletedNCT03791008

Assessment of Feasibility and Acceptability of Personalized Breast Cancer Screening

Personalized Breast Cancer Screening: Assessment of Its Feasibility and Acceptability in the National Health System

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
387 (actual)
Sponsor
Institut de Recerca Biomèdica de Lleida · Academic / Other
Sex
Female
Age
40 Years – 50 Years
Healthy volunteers
Accepted

Summary

The overall objective is to assess the acceptability and feasibility of offering personalized breast cancer (BC) screening. The specific objectives are: 1) To design an information system; 2) To evaluate the barriers and facilitators of the coordination of health care services and the screening program; 3) To develop a proof of concept of personalized screening; and 4) To evaluate cost-effectiveness. Methodology: 1. Prototype information system with basal and longitudinal variables relevant to a personalized screening system; 2. Qualitative study with focus groups and survey. The attitude and acceptability on a sample of 210 health professionals will be assessed; 3. Prospective observational study, for proof of concept. Participants will be professionals working in Primary Care, Population Breast Screening Program, or Hospital Breast Unit. It will include 385 women, aged 40-50 from the city of Lleida. Various indicators of acceptability and feasibility will be assessed in women and health professionals; 4. Probabilistic analytical models will be used to evaluate cost-effectiveness. The present protocol addresses the specific objective number 3, the proof of concept of personalised screening. Expected results: The investigators expect to provide valuable and necessary information for the design of personalized screening.

Conditions

Interventions

TypeNameDescription
OTHERRisk based screeningBreast cancer risk measurement, screening recommendations and shared decision making

Timeline

Start date
2019-01-30
Primary completion
2021-12-31
Completion
2021-12-31
First posted
2019-01-02
Last updated
2022-03-31

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT03791008. Inclusion in this directory is not an endorsement.